Phreesia, Inc. (NYSE:PHR – Get Free Report) insider Janet Gunzburg sold 2,768 shares of the stock in a transaction on Wednesday, April 10th. The stock was sold at an average price of $23.10, for a total value of $63,940.80. Following the completion of the sale, the insider now owns 36,132 shares of the company’s stock, valued at approximately $834,649.20. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Janet Gunzburg also recently made the following trade(s):
- On Monday, April 8th, Janet Gunzburg sold 1,709 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $38,657.58.
- On Tuesday, March 19th, Janet Gunzburg sold 2,817 shares of Phreesia stock. The shares were sold at an average price of $23.27, for a total value of $65,551.59.
- On Friday, February 9th, Janet Gunzburg sold 480 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total value of $13,440.00.
- On Thursday, February 1st, Janet Gunzburg sold 328 shares of Phreesia stock. The shares were sold at an average price of $25.99, for a total value of $8,524.72.
Phreesia Stock Performance
Phreesia stock opened at $23.58 on Friday. The company has a 50 day moving average price of $24.70 and a 200-day moving average price of $21.15. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.78 and a current ratio of 1.78. Phreesia, Inc. has a fifty-two week low of $12.05 and a fifty-two week high of $34.98. The company has a market capitalization of $1.33 billion, a PE ratio of -9.36 and a beta of 0.92.
Analyst Ratings Changes
A number of research analysts have recently weighed in on PHR shares. Stephens restated an “overweight” rating and set a $28.00 price objective on shares of Phreesia in a research report on Friday, March 22nd. Royal Bank of Canada restated a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a research report on Thursday, March 21st. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 price target on shares of Phreesia in a report on Friday, March 15th. Raymond James reaffirmed an “outperform” rating and issued a $30.00 price target (up previously from $25.00) on shares of Phreesia in a report on Friday, March 15th. Finally, Truist Financial assumed coverage on shares of Phreesia in a report on Monday, February 26th. They issued a “buy” rating and a $35.00 price target for the company. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $31.62.
Hedge Funds Weigh In On Phreesia
Several institutional investors have recently bought and sold shares of PHR. Brown Advisory Inc. increased its holdings in Phreesia by 22.2% during the fourth quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock valued at $91,451,000 after buying an additional 716,374 shares during the period. FMR LLC increased its holdings in Phreesia by 8.6% during the third quarter. FMR LLC now owns 7,856,551 shares of the company’s stock valued at $146,760,000 after buying an additional 624,456 shares during the period. Rock Springs Capital Management LP increased its holdings in Phreesia by 36.1% during the third quarter. Rock Springs Capital Management LP now owns 1,776,391 shares of the company’s stock valued at $33,183,000 after buying an additional 471,391 shares during the period. Norges Bank purchased a new position in Phreesia during the fourth quarter valued at approximately $8,199,000. Finally, BlackRock Inc. increased its holdings in Phreesia by 5.8% during the first quarter. BlackRock Inc. now owns 6,359,641 shares of the company’s stock valued at $167,640,000 after buying an additional 349,301 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.
About Phreesia
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Recommended Stories
- Five stocks we like better than Phreesia
- How to Invest in Small Cap Stocks
- 5 Trends You Need to Know This Quarter
- How to Find Undervalued Stocks
- MarketBeat Week in Review – 4/8 – 4/12
- Financial Services Stocks Investing
- You Can Follow BlackRock’s Market View for Your Money
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.